October 2008 - Volume 6 - Issue 5 : Expert Review of Anti-infective Therapy (original) (raw)

October 2008 - Volume 6 - Issue 5

• Foreword

  • Importance of antibiotic resistance and resistance mechanisms

  Expert Review of Anti-infective Therapy. October 2008: 6(5):549-550

• Editorial

  • Where does novel antibiotics R&D stand among other pharmaceutical products

  an industrial perspective?
  Glenn S Tillotson
  Expert Review of Anti-infective Therapy. October 2008: 6(5):551-552

• News in brief

  • New antibiotics needed to combat emerging resistant pathogens

  Expert Review of Anti-infective Therapy. October 2008: 6(5):553

  • Intelence™ reaches the EU market

  Expert Review of Anti-infective Therapy. October 2008: 6(5):553

  • Potential target for bursting the bugs

  Expert Review of Anti-infective Therapy. October 2008: 6(5):555

• Drug Profile

  • Establishing the role of tigecycline in an era of antimicrobial resistance

  Jason J Schafer, Debra A Goff
  Expert Review of Anti-infective Therapy. October 2008: 6(5):557-567

  • Entecavir

  a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients
  Pin-Nan Cheng, Ting-Tsung Chang
  Expert Review of Anti-infective Therapy. October 2008: 6(5):569-579

• Meeting Report

  • Emerging viruses

  risk of pandemic
  Patrick Labonté, Nabil G Seidah
  Expert Review of Anti-infective Therapy. October 2008: 6(5):581-583

• Key Paper Evaluation

  • Antiretroviral therapy during infancy

  essential intervention for resource-limited settings
  Brian S Eley
  Expert Review of Anti-infective Therapy. October 2008: 6(5):585-589

• Book Review

  • Pathogenic Fungi

  Insights in Molecular Biology
  Steven Bates
  Expert Review of Anti-infective Therapy. October 2008: 6(5):591-592

• Perspective

  • Potential of old-generation antibiotics to address current need for new antibiotics

  Matthew E Falagas, Alexandros P Grammatikos, Argyris Michalopoulos
  Expert Review of Anti-infective Therapy. October 2008: 6(5):593-600

• Review

  • Current challenges in treating MRSA

  what are the options?
  Natasha VDV Ratnaraja, Peter M Hawkey
  Expert Review of Anti-infective Therapy. October 2008: 6(5):601-618

  • Antimicrobial-resistant Streptococcus pneumoniae

  trends and management
  Michael R Jacobs
  Expert Review of Anti-infective Therapy. October 2008: 6(5):619-635

  • Emergence and management of drug-resistant enterococcal infections

  Cesar A Arias, Barbara E Murray
  Expert Review of Anti-infective Therapy. October 2008: 6(5):637-655

  • Multiresistant Enterobacteriaceae

  new threat of an old problem
  Johann DD Pitout
  Expert Review of Anti-infective Therapy. October 2008: 6(5):657-669

  • Clinical significance of extended-spectrum β-lactamases

  Jesús Rodríguez-Baño, Alvaro Pascual
  Expert Review of Anti-infective Therapy. October 2008: 6(5):671-683

  • Plasmid-mediated quinolone resistance

  Luis Martínez-Martínez, María Eliecer Cano, José Manuel Rodríguez-Martínez, Jorge Calvo, Álvaro Pascual
  Expert Review of Anti-infective Therapy. October 2008: 6(5):685-711